Prevalence, employment rate, and cost of schizophrenia in a high-income welfare society: A population-based study using comprehensive health and welfare registers

Schizophrenia Bulletin

Volumn 42, Issue 2, 2016, Pages 476-483

  Evensen, Stig ^a   Wisløff, Torbjørn ^a   Lystad, June Ullevoldsæter ^a   Bull, Helen ^a   Ueland, Torill ^a,b   Falkum, Erik ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cost of illness; Employment; Prevalence; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; EMPLOYMENT; FEMALE; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; MIDDLE AGED; NORWAY; PATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; SCHIZOPHRENIA; SCHOOL CHILD; UNEMPLOYMENT; YOUNG ADULT; ECONOMICS; PREVALENCE; SOCIAL WELFARE; STATISTICS AND NUMERICAL DATA;

ADULT; EMPLOYMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; PREVALENCE; REGISTRIES; SCHIZOPHRENIA; SOCIAL WELFARE; YOUNG ADULT;

EID: 84964859062     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv141     Document Type: Article

References (53)

1. Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr Bull. 2004;30:279-293.
2. Mangalore R, Knapp M. Cost of schizophrenia in England. J Ment Health Policy Econ. 2007;10:23-41.
3. Neil AL, Carr VJ, Mihalopoulos C, Mackinnon A, Morgan VA. Costs of psychosis in 2010: findings from the second Australian National Survey of Psychosis. Aust N Z J Psychiatry. 2014;48:169-182.
4. Rössler W, Salize HJ, van Os, J, Riecher-Rössler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005;15:399-409.
5. Rund BR, Ruud T. Costs of services for schizophrenic patients in Norway. Acta Psychiatr Scand. 1999;99:120-125.
6. Ekman M, Granström O, Omérov S, Jacob J, Landén M. Costs of bipolar disorder, depression, schizophrenia and anxiety. The right treatments can have significant positive socio-economic effects. Lakartidningen. 2014;111:1362-1364.
7. Perälä J, Suvisaari J, Saarni SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007;64:19-28.
8. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2:e141.
9. Johannessen JO. Schizofreni-forekomst i et norsk fylke, Rogaland. Nord Psykiatr Tidsskr 1985;39:217-223.
10. Johannessen JO. Schizophrenia-incidence and significance. Tidsskr Nor Laegeforen. 2002;122:2011-2014.
11. Nesvåg R, Knudsen GP, Bakken IJ, et al. Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: A registry-based study. Soc Psychiatry Psychiatr Epidemiol. 2015;50:1267-1276.
12. Ekman M, Granstrom O, Omerov S, Jacob J, Landen M. The societal cost of schizophrenia in Sweden. J Ment Health Policy Econ. 2013;16:13-25.
13. Kozma C, Dirani R, Canuso C, Mao L. Change in employment status over 52 weeks in patients with schizophrenia: An observational study. Curr Med Res Opin. 2011;27:327-333.
14. Jonsdottir A, Waghorn G. Psychiatric disorders and labour force activity. Ment Health Rev Jr 2015;20:13.
15. Helle S, Gråwe R. Employment and social benefit among persons with schizophrenia in Norway. Journal of the Norwegian Psychological Association 2007;44:1358-1362.
16. Melle I, Friis S, Hauff E, Vaglum P. Social functioning of patients with schizophrenia in high-income welfare societies. Psychiatr Serv. 2000;51:223-228.
17. Tandberg M, Sundet K, Andreassen OA, Melle I, Ueland T. Occupational functioning, symptoms and neurocognition in patients with psychotic disorders: investigating subgroups based on social security status. Soc Psychiatry Psychiatr Epidemiol. 2013;48:863-874.
18. Hu TW. Perspectives: An international review of the national cost estimates of mental illness, 1990-2003. J Ment Health Policy Econ. 2006;9:3-13.
19. Henriksson F, Jönsson B. The economic cost of multiple sclerosis in Sweden in 1994. Pharmacoeconomics. 1998;13:597-606.
20. Henriksson F, Fredrikson S, Masterman T, Jönsson B. Costs, quality of life and disease severity in multiple sclerosis: A cross-sectional study in Sweden. Eur J Neurol. 2001;8:27-35.
21. OECD. Purchasing Power Parities for GDP and Related Indicators. Paris, France: OECD Publishing; 2015.
22. Huseby BM, Gjøen IJ, Sundet IB, et al. Samdata Sepsialisthelsetjenesten 2012. Oslo, Norway: Helsedirektoratet; 2013.
23. Helsedirektoratet. Information on the IPLOS Register. Oslo, Norway: Norwegian Directorate of Health; 2013.
24. Statistics Norway. Population and Population Changes. Oslo: Statistics Norway; 2015.
25. Indergård PJ, Skiri J-A, Solbakken T, Urfjell B. Aktivitetsdata Fra Psykisk Helsevern for Voksne Og Tverrfaglig Spesialisert Behandling Av Rusmiddelmisbruk 2012. Oslo, Norway: The Norwegian Directorate of Health; 2013.
26. Statistics Norway. KOSTRA - Municipality-State-reporting. Oslo: Statistics Norway; 2015.
27. Tenden L, Pettersen L. Omsorgstjenester Bransjestatistikk 2012: NHO Service; 2012.
28. Statistics Norway. Students at Universities and Colleges: Statistics Norway. Oslo: Statistics Norway; 2015.
29. Ellingsen J. Utviklingen i uførepensjon per 31. desember 2012. Oslo, Norway: Arbeids- og velferdsdirektoratet; 2013.
30. Kann IC, Kristoffersen P, Thune O. Arbeidsavklaringspenger - gjennomstrømming og avgang fra ordningen. Arbeid og Velferd 2013;1:41-57.
31. Koopmanschap MA, Rutten FF. A practical guide for calculating indirect costs of disease. Pharmacoeconomics. 1996;10:460-466.
32. Statistics Norway. Tax Statistics for Personal Tax Payers. Oslo: Statistics Norway; 2015.
33. Statistics Norway. Average Labour Costs Per Full- Time Equivalent Employee, by Industry (SIC2007). Oslo: Statistics Norway; 2015.
34. Statistics Norway. Consumer Price Index. Oslo: Statistics Norway; 2015.
35. Krabbendam L, Van Os, J. Schizophrenia and urbanicity: A major environmental influence-conditional on genetic risk. Schizophr Bull. 2005;31:795-799.
36. Cantor-Graae E, Selten JP. Schizophrenia and migration: A meta- Analysis and review. Am J Psychiatry. 2005;162:12-24.
37. Høydahl E. Befolkningsvekst rundt Oslo. Samfunnsspeilet/Statistisk sentralbyrå 2010;5:11-19.
38. Statistics Norway. Population and Land Area in Urban Settlements. Oslo: Statistics Norway; 2015.
39. Di-Meglio E, Rusu C, Rybkowska A. Living Conditions in Europe. Luxembourg, Europe: Publications Office of the European Union; 2014.
40. OECD. Making Mental Health Count: The Social and Economic Costs of Neglecting Mental Health Care. OECD Health Policy Studies, Paris, France: OECD Publishing; 2014.
41. Ministerråd N. Kvalitetsmåling I Psykiatrien I De Nordiske lande. Copenhagen, Denmark: Nordisk Ministerråd; 2011.
42. OECD. Mental Health and Work: Norway. Paris, France: OECD Publishing;2013.
43. Melle I, Larsen TK, Haahr U, et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry. 2004;61:143-150.
44. Ruud T. Mental health quality and outcome measurement and improvement in Norway. Curr Opin Psychiatry. 2009;22:631-635.
45. Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jørgensen HA. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry. 2009;9:24.
46. Volkow ND. Substance use disorders in schizophrenia- clinical implications of comorbidity. Schizophr Bull. 2009;35:469-472.
47. Kavanagh DJ, McGrath J, Saunders JB, Dore G, Clark D. Substance misuse in patients with schizophrenia: epidemiology and management. Drugs. 2002;62:743-755.
48. Falkum E, Evensen S, Lystad J, Bull HC, Ueland T. Effektevaluering av Jobbmestrende Oppfølging (JMO): Kognitiv Atferdsterapi og Kognitiv Trening I Arbeidsrehabilitering for Personer Med Psykoselidelser. Oslo, Norway: Helsedirektoratet; 2015.
49. Knapp M, Patel A, Curran C, et al. Supported employment: cost-effectiveness across six European sites. World Psychiatry. 2013;12:60-68.
50. Bush PW, Drake RE, Xie H, McHugo GJ, Haslett WR. The long- Term impact of employment on mental health service use and costs for persons with severe mental illness. Psychiatr Serv. 2009;60:1024-1031.
51. Oiesvold T, Nivison M, Hansen V, Skre I, Ostensen L, Sørgaard KW. Diagnosing comorbidity in psychiatric hospital: challenging the validity of administrative registers. BMC Psychiatry. 2013;13:13.
52. Nygaard E, Wie-Groenhof A. Drap i Norge i perioden 2004- 2009. Oslo, Norway: Departementenes servicesenter; 2010.
53. Birkenaes AB, Søgaard AJ, Engh JA, et al. Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population. J Clin Psychiatry. 2006;67:425-433.